Institution
University of Erlangen-Nuremberg
Education•Erlangen, Bayern, Germany•
About: University of Erlangen-Nuremberg is a education organization based out in Erlangen, Bayern, Germany. It is known for research contribution in the topics: Population & Immune system. The organization has 42405 authors who have published 85600 publications receiving 2663922 citations.
Topics: Population, Immune system, Breast cancer, Catalysis, Transplantation
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Doped TiO(2) and in particular TiO (2) nanotubes are examined and large potential for enhanced and novel functional features are provided.
Abstract: TiO(2) is one of the most investigated compounds in contemporary materials science. Due to a set of virtually unique electronic properties, it finds intense use in photoelectrochemical applications such as photocatalysis or solar cells. The main drawback in view of direct exploitation of solar-light-based effects is its large band gap of >3 eV. Visible-light-activated TiO(2) can be prepared by doping (band-gap engineering) through incorporation or decoration with other metal ions, nonmetal ions, and semiconductors. Most recently, efforts in TiO(2) research have been even more intensified by the finding of self-organized nanotubular oxide architectures that can be prepared by a simple but optimized anodization of Ti metal surfaces. These nanotubular geometries provide large potential for enhanced and novel functional features. This Review examines doped TiO(2) and in particular TiO(2) nanotubes. Various types of dopants, doping methods, and applications of modified TiO(2) nanotubes are discussed.
329 citations
••
University of Western Ontario1, University of California, San Diego2, University of Amsterdam3, University of Cambridge4, Katholieke Universiteit Leuven5, Cliniques Universitaires Saint-Luc6, Hannover Medical School7, Asan Medical Center8, University of Erlangen-Nuremberg9, University of Kiel10, Boehringer Ingelheim11
TL;DR: In this short-term study, risankizumab was more effective than placebo for inducing clinical remission in patients with active Crohn's disease and selective blockade of interleukin-23 via inhibition of p19 might be a viable therapeutic approach in Crohn’s disease.
329 citations
••
TL;DR: The presence of depressive disorders after bariatric surgery significantly predicted attenuated post-surgical improvements and may signal a need for clinical attention.
329 citations
••
TL;DR: Tube current modulation governed by x-ray attenuation during CT (computed tomography) acquisition can lead to noise reduction which in turn can be used to achieve patient dose reduction without loss in image quality.
Abstract: The physical principles of dose reduction in computed tomography (CT) by anatomy-oriented attenuation-based tube current modulation, as discussed elsewhere in this volume (see Chap. 4), were tested in a first clinical patient study. Our aim was to reduce the dose applied in CT by current modulation and without a loss of image quality. Dose reduction was measured by the reduction of the mAs product, and image quality was assessed subjectively by experienced radiologists.
329 citations
Authors
Showing all 42831 results
Name | H-index | Papers | Citations |
---|---|---|---|
Hermann Brenner | 151 | 1765 | 145655 |
Richard B. Devereux | 144 | 962 | 116403 |
Manfred Paulini | 141 | 1791 | 110930 |
Daniel S. Berman | 141 | 1363 | 86136 |
Peter Lang | 140 | 1136 | 98592 |
Joseph Sodroski | 138 | 542 | 77070 |
Richard J. Johnson | 137 | 880 | 72201 |
Jun Lu | 135 | 1526 | 99767 |
Michael Schmitt | 134 | 2007 | 114667 |
Jost B. Jonas | 132 | 1158 | 166510 |
Andreas Mussgiller | 127 | 1059 | 73778 |
Matthew J. Budoff | 125 | 1449 | 68115 |
Stefan Funk | 125 | 506 | 56955 |
Markus F. Neurath | 124 | 934 | 62376 |
Jean-Marie Lehn | 123 | 1054 | 84616 |